Dennis Bastas is the Executive Chairman and CEO of the Arrotex Australia Group of companies and Chairman of Juno Pharmaceuticals. In 2015, Dennis acquired the Arrow business, in partnership with Strides Pharmaceuticals, from Aspen Pharmaceuticals. After buying out the Strides ownership in 2019, he merged the business with Apotex Australia to form Arrotex Pharmaceuticals. Prior to this, Dennis founded Ascent Pharmaceuticals and as CEO went on to build a successful Australian and Asian generic pharmaceutical company which was ultimately sold to Actavis Pharmaceuticals. Dennis also developed the Central Healthcare group of companies in 2010, which he sold to Sigma Pharmaceuticals in 2014. Dennis is also the major shareholder and Chairman of myDNA, a world leading pharmacogenomic and health genomic platform technology.
Chairman & Group CEO, Arrotex Australia Group
DENNIS BASTAS
Session:
Alan Russell Oration: Global search for innovation
– learnings for Community Pharmacy in Australia
When:
Thursday 19 March, 12.15pm –1.00pm
Proudly sponsored by:
SESSION SPONSOR
PROGRAM SPONSOR
MAJOR SPONSOR
VIEW ALL
PRINCIPAL SPONSOR
APP2020 SPONSORS
.png)
THANK YOU TO OUR SPONSORS
PRINCIPAL SPONSORS:
.png)
MAJOR SPONSORS:
SESSION SPONSORS
PROGRAM SPONSORS
MAJOR SPONSORS
PRINCIPAL SPONSORS
APP2022 SPONSORS
SPONSORSHIP & TRADE
ENQUIRE NOW
KEEP ME UPDATED
SUBSCRIBE FOR UPDATES
LET'S GET SOCIAL
(c) 2022 APP Conference 2023. All Rights Reserved.
#APP2023
Events Division
The Pharmacy Guild of Australia
Queensland Branch
07 3831 9246
SITE CREDITS
CONTACT US
